Home

Moderna, Inc. - Common Stock (MRNA)

33.30
+0.51 (1.54%)
NASDAQ · Last Trade: Jul 10th, 11:13 AM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors

Detailed Quote

Previous Close32.79
Open33.47
Bid33.29
Ask33.30
Day's Range32.98 - 34.17
52 Week Range23.15 - 129.39
Volume4,394,381
Market Cap12.89B
PE Ratio (TTM)-3.814
EPS (TTM)-8.7
Dividend & YieldN/A (N/A)
1 Month Average Volume9,911,004

Chart

About Moderna, Inc. - Common Stock (MRNA)

Moderna Inc is a biotechnology company focused on developing innovative messenger RNA (mRNA) therapeutics and vaccines for a wide array of diseases. Utilizing its proprietary mRNA technology platform, Moderna aims to harness the body's own cellular machinery to produce proteins that can help prevent or treat illnesses, including infectious diseases, cancer, and rare genetic disorders. The company gained significant attention for its development of an effective COVID-19 vaccine, but its pipeline also includes various other candidates in different stages of clinical development aimed at addressing unmet medical needs. Through its research and development efforts, Moderna seeks to transform the field of medicine and improve patient outcomes globally. Read More

News & Press Releases

Moderna’s Covid Vaccine Gets Full FDA Approval For Use In Children 6 Months And Olderstocktwits.com
The vaccine was previously available for pediatric populations under Emergency Use Authorization only.
Via Stocktwits · July 10, 2025
Market Monitor News July 09 BMO (Moderna & Merit Medical System UP - Solar & Bank Stocks DOWN)chartmill.com
Wall Street Holds Its Breath: Tariff Tantrums, Solar Slaps, and a Surge from Moderna
Via Chartmill · July 9, 2025
Top S&P500 movers in Tuesday's sessionchartmill.com
Uncover the latest developments among S&P500 stocks in today's session. Stay tuned to the S&P500 index's top gainers and losers on Tuesday.
Via Chartmill · July 8, 2025
Medical Groups Sue RFK Jr. For Assault On Science Over Unlawful COVID-19 Vaccine Rollbacksbenzinga.com
Major health groups sue HHS and Robert F. Kennedy Jr. over COVID-19 vaccine policy changes for children and pregnant individuals.
Via Benzinga · July 8, 2025
Discover which S&P500 stocks are making waves on Tuesday.chartmill.com
Let's have a look at what is happening on the US markets in the middle of the day on Tuesday. Below you can find the top S&P500 gainers and losers in today's session.
Via Chartmill · July 8, 2025
Microchip Technology, Tesla, Humacyte And Other Big Stocks Moving Higher On Tuesdaybenzinga.com
Via Benzinga · July 8, 2025
Cooling US Bird Flu Wave Removes Tailwind For Moderna, Novavax, CureVac, Traws Pharmastocktwits.com
The CDC reportedly deactivated its bird flu emergency response last week, folding surveillance into its regular flu tracking and ending animal infection updates.
Via Stocktwits · July 8, 2025
2 Beaten-Down Stocks to Buy and Holdfool.com
Via The Motley Fool · July 5, 2025
Where Will Moderna Be in 10 Years?fool.com
Via The Motley Fool · July 5, 2025
Why Moderna Stock Was So Healthy This Weekfool.com
Via The Motley Fool · July 4, 2025
RFK Jr. Influence Evident As Vaccine Chief Overrules Scientists, Limits COVID-19 Vaccine Approvalbenzinga.com
FDA vaccine head Vinay Prasad restricted Moderna and Novavax COVID vaccines to high-risk groups, overriding staff advice amid concerns about rare side effects.
Via Benzinga · July 3, 2025
CDC Greenlights Vaccines From Pfizer, Moderna, GSK Amid Shakeup Of Advisory Panelstocktwits.com
The agency expanded its RSV and meningococcal vaccine guidance to cover younger age groups and new formulations.
Via Stocktwits · July 2, 2025
Which S&P500 stocks are moving on Wednesday?chartmill.com
Stay updated with the movement of S&P500 stocks in today's session. Discover which S&P500 stocks are making waves on Wednesday.
Via Chartmill · July 2, 2025
10 Health Care Stocks With Whale Alerts In Today's Sessionbenzinga.com
Via Benzinga · July 2, 2025
RFK Jr. Just Did The Unexpected. He Helped Moderna.investors.com
The new Health Secretary reportedly recommended Moderna's RSV vaccine for a broader group of adults.
Via Investor's Business Daily · July 2, 2025
Explore the top gainers and losers within the S&P500 index in today's session.chartmill.com
Wondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Wednesday.
Via Chartmill · July 2, 2025
Tuesday's session: top gainers and losers in the S&P500 indexchartmill.com
Wondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Tuesday.
Via Chartmill · July 1, 2025
Got $200? 2 Biotech Stocks to Buy and Hold Foreverfool.com
Via The Motley Fool · July 1, 2025
Did Down-And-Out Moderna Just Unlock The Key To Its Future Profitability?investors.com
Shares have long struggled, but things could be looking up for Moderna stock in the face of new flu shot results.
Via Investor's Business Daily · June 30, 2025
Moderna's mRNA Flu Vaccine Outperforms Standard Shotsbenzinga.com
Moderna's mRNA flu vaccine showed 26.6% better efficacy than a standard flu shot in adults 50 and older during a global Phase 3 study.
Via Benzinga · June 30, 2025
What's going on in today's pre-market session: S&P500 moverschartmill.com
Before the opening bell on Monday, let's take a glimpse of the US markets and explore the S&P500 top gainers and losers in today's pre-market session.
Via Chartmill · June 30, 2025
Moderna Stock Surges Pre-Market As Flu Vaccine Shows Positive Results In Late-Stage Trialstocktwits.com
The data is key to receiving approvals for both the individual vaccine candidate and the company’s seasonal flu-COVID combination vaccine candidate.
Via Stocktwits · June 30, 2025
Moderna Announces Positive Phase 3 Results for Seasonal Influenza Vaccine
mRNA-1010 demonstrated superior relative vaccine efficacy that was 26.6% (95% CI; 16.7%, 35.4%) higher than a licensed standard-dose seasonal influenza vaccine in adults aged 50 years and older
Via ACCESS Newswire · June 30, 2025
CDC Vaccine Panel Overhauled by RFK Jr. Votes To Drop Mercury Preservative, Critics Sound Alarmstocktwits.com
The panel also voted to recommend Merck’s RSV antibody drug Enflonsia for newborns whose mothers didn’t receive prenatal protection.
Via Stocktwits · June 26, 2025
RFK Jr. Overhauls CDC Vaccine Panel, Sparking Expert Backlash, Boycott From Top Medical Groupbenzinga.com
Health Secretary Robert F. Kennedy Jr.'s newly reconstituted vaccine advisory panel is facing criticism from medical experts.
Via Benzinga · June 26, 2025